ACE Inhibitors Market Forecasted to Surge to $9 Billion by 2028 Amid Growing Cardiovascular and Hypertension Concerns
31 janv. 2024 09h37 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "ACE Inhibitors Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The global ACE inhibitors market is projected to...
Antihypertensive Drug Market to Expand with Promising CAGR of 4.7% through 2030: Regional Growth Opportunities for Diuretics, ACE Inhibitors, Calcium Channel Blockers, Vasodilators, Beta-Adrenergic Blockers
30 janv. 2024 07h11 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Antihypertensive Drug Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Atherosclerotic Cardiovascular Disease Market Set to Exhibit Growth by 2032, Driven by Advancements and Emerging Therapies
24 janv. 2024 10h32 HE
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ...
Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028
21 sept. 2023 09h58 HE
|
Research and Markets
Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Global Atherosclerosis Drugs Market to Reach $27.71 Billion by 2032, Driven by Rising Cardiovascular Disorders
13 sept. 2023 10h28 HE
|
Research and Markets
Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Atherosclerosis Drugs Market By Drug Type, By Route of Administration, By Distribution Channel: Global Opportunity Analysis and Industry Forecast,...
North America Hemoglobinopathies Market Analysis Report 2022: Focus on Thalassemia and Sickle Cell Disease - Forecasts to 2028
07 mars 2023 10h33 HE
|
Research and Markets
Dublin, March 07, 2023 (GLOBE NEWSWIRE) -- The "North America Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution...
Global Nephrology Drugs Market Projected to Garner a Revenue of $21,454.5 Million and Rise at a CAGR of 6.0% during the Forecast Period 2021-2028 [170-Pages] | Exclusive by Research Dive
06 févr. 2023 09h01 HE
|
Research Dive
New York, USA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global nephrology drugs market is anticipated to generate a revenue of $21,454.5 million and...
Global Hemoglobinopathies Market Report 2022: Featuring Abbott, Sanofi, Danaher, Pfizer, Merck & More
10 janv. 2023 10h18 HE
|
Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel,...
Nesvik Pharmaceuticals, Inc., Receives Updated U.S. FDA Establishment Registration in Light of New Product Development
28 août 2018 10h10 HE
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on...
Marina Biotech Appoints Amit Shah as Chief Financial Officer
05 oct. 2017 08h30 HE
|
Marina Biotech, Inc.
City of Industry, CA, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...